Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

RARECARENet Working Group

doi:10.1016/j.ejso.2017.08.019

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

RARECARENet Working Group

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network.

Original language	English
Pages (from-to)	46-51
Number of pages	6
Journal	European Journal of Surgical Oncology
Volume	45
Issue number	1
DOIs	https://doi.org/10.1016/j.ejso.2017.08.019
Publication status	Published - Jan 2019

Bibliographical note

Publisher Copyright:
© 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology

Keywords

Liver metastases
Neuroendocrine tumours
Pancreas
Rare cancers

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejso.2017.08.019

Cite this

@article{57787a31882b46149e3274fb5d90d5b9,

title = "Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours",

abstract = "Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network.",

keywords = "Liver metastases, Neuroendocrine tumours, Pancreas, Rare cancers",

author = "{RARECARENet Working Group} and Lykoudis, {Panagis M.} and Stefano Partelli and Francesca Muffatti and Martyn Caplin and Massimo Falconi and Fusai, {Giuseppe K.} and Monika Hackl and {Van Eycken}, Elizabeth and Kris Henau and Nadya Dimitrova and Mario Sekerija and Ladislav Du{\v s}ek and Margit M{\"a}gi and Nea Malila and Maarit Leinonen and Michel Velten and Xavier Troussard and Veronique Bouvier and Guizard, {Anne Val{\'e}rie} and Bouvier, {Anne Marie} and Patrick Arveux and Marc Maynadi{\'e} and Woronoff, {Anne Sophie} and Michel Robaszkiewicz and Isabelle Baldi and Alain Monnereau and Brigitte Tretarre and Marc Colonna and Florence Molini{\'e} and Simona Bara and Claire Schvartz and B{\'e}n{\'e}dicte Lap{\^o}tre-Ledoux and Pascale Grosclaude and Roland Stabenow and Sabine Luttmann and Alice Nennecke and Jutta Engel and Gabriele Schubert-Fritschle and Jan Heidrich and Bernd Holleczek and J{\'o}nasson, {J{\'o}n Gunnlaugur} and Kerri Clough-Gorr and Harry Comber and Guido Mazzoleni and Adriano Giacomin and Sardo, {Antonella Sutera} and Alessandro Barchielli and Diego Serraino and {De Angelis}, Roberta and Jem Rashbass",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology",

year = "2019",

month = jan,

doi = "10.1016/j.ejso.2017.08.019",

language = "English",

volume = "45",

pages = "46--51",

journal = "European Journal of Surgical Oncology",

issn = "0748-7983",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Treatment challenges in and outside a specialist network setting

T2 - Pancreatic neuroendocrine tumours

AU - RARECARENet Working Group

AU - Lykoudis, Panagis M.

AU - Partelli, Stefano

AU - Muffatti, Francesca

AU - Caplin, Martyn

AU - Falconi, Massimo

AU - Fusai, Giuseppe K.

AU - Hackl, Monika

AU - Van Eycken, Elizabeth

AU - Henau, Kris

AU - Dimitrova, Nadya

AU - Sekerija, Mario

AU - Dušek, Ladislav

AU - Mägi, Margit

AU - Malila, Nea

AU - Leinonen, Maarit

AU - Velten, Michel

AU - Troussard, Xavier

AU - Bouvier, Veronique

AU - Guizard, Anne Valérie

AU - Bouvier, Anne Marie

AU - Arveux, Patrick

AU - Maynadié, Marc

AU - Woronoff, Anne Sophie

AU - Robaszkiewicz, Michel

AU - Baldi, Isabelle

AU - Monnereau, Alain

AU - Tretarre, Brigitte

AU - Colonna, Marc

AU - Molinié, Florence

AU - Bara, Simona

AU - Schvartz, Claire

AU - Lapôtre-Ledoux, Bénédicte

AU - Grosclaude, Pascale

AU - Stabenow, Roland

AU - Luttmann, Sabine

AU - Nennecke, Alice

AU - Engel, Jutta

AU - Schubert-Fritschle, Gabriele

AU - Heidrich, Jan

AU - Holleczek, Bernd

AU - Jónasson, Jón Gunnlaugur

AU - Clough-Gorr, Kerri

AU - Comber, Harry

AU - Mazzoleni, Guido

AU - Giacomin, Adriano

AU - Sardo, Antonella Sutera

AU - Barchielli, Alessandro

AU - Serraino, Diego

AU - De Angelis, Roberta

AU - Rashbass, Jem

PY - 2019/1

Y1 - 2019/1

N2 - Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network.

AB - Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network.

KW - Liver metastases

KW - Neuroendocrine tumours

KW - Pancreas

KW - Rare cancers

UR - http://www.scopus.com/inward/record.url?scp=85032974666&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2017.08.019

DO - 10.1016/j.ejso.2017.08.019

M3 - Article

C2 - 29126671

AN - SCOPUS:85032974666

SN - 0748-7983

VL - 45

SP - 46

EP - 51

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

IS - 1

ER -

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this